---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-000995"
form_type: "8-K"
ticker: "GRCE"
cik: "0001444192"
company_name: "Grace Therapeutics, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:50:09.963026+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Grace Therapeutics amends severance for CEO (12-18 mo) and 4 execs (6 mo) as of Jan 10, 2026

## Summary
- CEO Prashant Kohli gets 12 mo base salary (no CIC) or 18 mo base+target bonus (CIC) plus COBRA.
- Four other executives get 6 mo base salary (no CIC) or 6 mo base+target bonus (CIC) plus COBRA.
- Unvested equity forfeited on termination without Cause absent CIC; fully vests if terminated/resigned within 12 mo after CIC.
- Amendments effective January 10, 2026; prior severance terms superseded.

## SEC filing metadata
- accession: 0001140361-26-000995
- form_type: 8-K
- ticker: GRCE
- cik: 0001444192
- company_name: Grace Therapeutics, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1444192/000114036126000995/0001140361-26-000995-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1444192/000114036126000995/ef20062691_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-000995
- JSON: https://secwatch.observer/filing/0001140361-26-000995.json
- Plain text: https://secwatch.observer/filing/0001140361-26-000995.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.